BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3064191)

  • 21. [Chemotherapy and rectal cancer].
    Michel P; Di Fiore F
    Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
    Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adenocarcinoma of the rectum: role of preoperative radiotherapy for the preservation of the sphincter function].
    Corvò R
    Recenti Prog Med; 2001 Jan; 92(1):41-4. PubMed ID: 11260969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant treatment in rectal cancer].
    Lise M; Nitti D; Chemello F; Zane D; Taboga L; De Carli GL; Bachi V; Civalleri D; Bonalumi U
    Ann Ital Chir; 1992; 63(3):321-32. PubMed ID: 1443998
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adjuvant treatments in resectable cancer of the rectum: preoperative radiotherapy, postoperative radiation- and chemotherapy or nothing?].
    Gérard A; Pector JC; Van Houtte P; Bleiberg H
    Ann Chir; 1993; 47(4):294-8; discussion 298-301. PubMed ID: 8352504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.
    Wong RK; Berry S; Spithoff K; Simunovic M; Chan K; Agboola O; Dingle B;
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):265-71. PubMed ID: 20398849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
    Gelber RD; Goldhirsch A; Cole BF; Wieand HS; Schroeder G; Krook JE
    J Natl Cancer Inst; 1996 Aug; 88(15):1039-45. PubMed ID: 8683634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
    Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative "chemoradiation" for stages II and III rectal carcinoma.
    Stryker SJ; Kiel KD; Rademaker A; Shaw JM; Ujiki GT; Poticha SM
    Arch Surg; 1996 May; 131(5):514-8; discussion 518-9. PubMed ID: 8624198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term complete response in a case of unresectable rectal cancer following chemoradiation].
    Musha N; Sunami E; Sasaki M; Saito H; Sando N; Setu Y; Setu M; Oka K
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):131-3. PubMed ID: 10660746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.
    Breugom AJ; Swets M; Bosset JF; Collette L; Sainato A; Cionini L; Glynne-Jones R; Counsell N; Bastiaannet E; van den Broek CB; Liefers GJ; Putter H; van de Velde CJ
    Lancet Oncol; 2015 Feb; 16(2):200-7. PubMed ID: 25589192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment.
    Habr-Gama A; de Souza PM; Ribeiro U; Nadalin W; Gansl R; Sousa AH; Campos FG; Gama-Rodrigues J
    Dis Colon Rectum; 1998 Sep; 41(9):1087-96. PubMed ID: 9749491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolongation of the disease-free interval in surgically treated rectal carcinoma.
    Gastrointestinal Tumor Study Group
    N Engl J Med; 1985 Jun; 312(23):1465-72. PubMed ID: 2859523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma.
    Klimberg VS; Langston JD; Maners A; Gocio JC; Hutchins LF; Lang NP; Westbrook KC; Broadwater JR
    Am J Surg; 1992 Nov; 164(5):433-5; discussion 436. PubMed ID: 1443366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
    Holmes EC; Hill LD; Gail M
    Ann Surg; 1985 Sep; 202(3):335-41. PubMed ID: 3899029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.